Hangzhou DAC Biotech Co., Ltd
Hangzhou
About Hangzhou DAC Biotech Co., Ltd
Hangzhou DAC Biotech provides an ADC drug platform with over 50 new intelligent linkers (including site-specific conjugation); 5 types of high-activity small molecule series compounds with different mechanisms; perfect antibody discovery, engineering transformation, and production process optimization technology; complete ADC drug animal in vivo and in vitro evaluation, drug structure confirmation, analytical method development and verification, and other services.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $171.7M
- Funding stage: Late Stage Venture
- Last round: Series C (May 2021)
- Website: dacbiotech.com
- Phone: 86-571-56050590
Industries & Categories
Biotechnology, Health Care, Medical
Canonical: https://fsome.com/organization/hangzhou-dac-biotech-co-ltd-96119 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.